PPT-Updated 2011 WHO Rubella Vaccine Position Paper and Implications for Regions and Countries

Author : elizabeth | Published Date : 2024-06-10

10 th Measles Initiative Meeting September 1314 2011 Washington DC Susan E Reef CDCGIDDEEB Peter M Strebel WHOHQIVBEPI Outline Global and regional status CRS burden

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Updated 2011 WHO Rubella Vaccine Positio..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Updated 2011 WHO Rubella Vaccine Position Paper and Implications for Regions and Countries: Transcript

10 th Measles Initiative Meeting September 1314 2011 Washington DC Susan E Reef CDCGIDDEEB Peter M Strebel WHOHQIVBEPI Outline Global and regional status CRS burden Vaccine uptake and regional goals. Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . Regional MR TAG . Nairobi, Kenya . June 2-3 , 2015 . Outline . Background . Epidemiology of Rubella . Strategic options for rubella control AFR . MR introduction progress noted issues related to MR introduction in AFR . 10. th. Measles Initiative Meeting. September 13-14, 2011, . Washington DC. Susan. E. Reef, CDC/GID/DEEB. Peter M. Strebel, WHO/HQ/IVB/EPI. Outline. Global and regional status . CRS burden. Vaccine uptake and regional goals. 11. th. Annual Meeting . Measles and Rubella Initiative. Washington, DC. Peter Strebel, WHO/EPI. The mission of the Decade of Vaccines is to extend, by 2020 and beyond, the full benefits of immunization to all people, regardless of where they are born, who they are, or where they live.". 11. th. Annual Meeting . Measles and Rubella Initiative. Washington, DC. Peter Strebel, WHO/EPI. The mission of the Decade of Vaccines is to extend, by 2020 and beyond, the full benefits of immunization to all people, regardless of where they are born, who they are, or where they live.". Regional MR TAG . Nairobi, Kenya . June 2-3 , 2015 . Outline . Background . Epidemiology of Rubella . Strategic options for rubella control AFR . MR introduction progress noted issues related to MR introduction in AFR . Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . --Who We Are--. Stephen Cochi, . MD, MPH. Global . Immunization Division. Centers . for . Disease Control & Prevention. What is the Measles & Rubella Initiative? . Anne Ray Charitable Trust. 10. th. Measles Initiative Meeting. September 13-14, 2011, . Washington DC. Susan. E. Reef, CDC/GID/DEEB. Peter M. Strebel, WHO/HQ/IVB/EPI. Outline. Global and regional status . CRS burden. Vaccine uptake and regional goals. M&RI Partners’ Meeting. Michael F Thomas, . Director Vaccine Implementation. September 2017, Washington DC. Page: . 1. Reach every child. . Measles and Rubella support in Gavi countries by end of 2016. pregnancy What you need to know What is Rubella (German measles)? Rubella is a contagious disease caused by a virus. How is it spread? Rubella is spread by close contact with an infected person, th 20000 or more infants are perhaps born with CRS each year in Latin American and Caribbean ABSTRACT larly during the first trimester). In suchblindness, deafness, cardiovascular[congenital rubella synd 343 28 Rubella The disease Rubella is a mild disease caused by a togavirus. There may be a mild prodromal illness involving a low-grade fever, malaise, coryza and mild conjunctivitis. Lymphadenopath Opening Comments & Perspectives. Dr. Suresh Jadhav. Executive Director. Serum Institute of India Pvt. Ltd.,. ssj@seruminstitute.com. . We, at Serum Institute of India Pvt. Ltd., feel proud of being a partner to PAHO / WHO in achieving what is designated to be a historical achievement in eradication of Measles & Rubella diseases from the Americas..

Download Document

Here is the link to download the presentation.
"Updated 2011 WHO Rubella Vaccine Position Paper and Implications for Regions and Countries"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.